June 25, 2021

Notable Analyst Upgrades and Downgrades for Week of June 21, 2021

 



Upgrades:

 


Eastman Chemical (NYSE:EMN) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a research note issued to investors on Monday, The Fly reports. The firm presently has a $145.00 target price on the basic materials company’s stock. Scotiabank’s price objective indicates a potential upside of 27.03% from the stock’s current price.

Other analysts also recently issued research reports about the stock. KeyCorp lifted their price target on shares of Eastman Chemical from $126.00 to $135.00 and gave the company an “overweight” rating in a research note on Monday, May 3rd. The Goldman Sachs Group raised shares of Eastman Chemical from a “neutral” rating to a “buy” rating and set a $148.00 price objective for the company in a research note on Tuesday, May 11th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Eastman Chemical from $132.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, June 14th. Wolfe Research assumed coverage on Eastman Chemical in a research report on Wednesday, June 9th. They set an “outperform” rating on the stock. Finally, Tudor Pickering downgraded Eastman Chemical from a “buy” rating to a “hold” rating and set a $117.00 price target on the stock. in a research report on Monday, May 3rd. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $110.31. Read more …

 


Accenture (NYSE:ACN) was upgraded by stock analysts at Exane BNP Paribas from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

A number of other research firms have also issued reports on ACN. Barclays lifted their target price on Accenture from $300.00 to $310.00 and gave the company an “overweight” rating in a report on Monday, March 22nd. BMO Capital Markets lifted their target price on Accenture from $292.00 to $302.00 and gave the company a “market perform” rating in a report on Friday, March 19th. They noted that the move was a valuation call. Susquehanna lifted their target price on Accenture from $290.00 to $325.00 and gave the company a “positive” rating in a report on Friday, March 19th. Societe Generale lifted their target price on Accenture from $313.00 to $329.00 and gave the company a “buy” rating in a report on Tuesday, June 15th. Finally, Royal Bank of Canada lifted their target price on Accenture from $278.00 to $301.00 in a report on Friday, March 19th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Accenture presently has a consensus rating of “Buy” and a consensus target price of $288.52. Read more …

 


Welltower (NYSE:WELL) was upgraded by analysts at Scotiabank from a “sector underperform” rating to a “sector perform” rating in a report released on Wednesday, Analyst Price Targets reports. The brokerage currently has a $83.00 price target on the real estate investment trust’s stock, up from their prior price target of $68.00. Scotiabank’s price objective points to a potential upside of 0.95% from the company’s previous close.

A number of other brokerages also recently commented on WELL. Morgan Stanley raised their price objective on Welltower from $76.00 to $79.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 7th. Deutsche Bank Aktiengesellschaft raised their target price on Welltower from $76.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, June 3rd. Evercore ISI upgraded Welltower from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $77.00 to $86.00 in a research report on Monday, June 14th. Mizuho raised their target price on Welltower from $60.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 28th. Finally, Raymond James upgraded Welltower from a “market perform” rating to a “strong-buy” rating and set a $92.00 target price for the company in a research report on Tuesday, June 15th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $73.59. Read more …

 

 


Magna International (NYSE:MGA) (TSE:MG) was upgraded by investment analysts at The Goldman Sachs Group from a "neutral" rating to a "buy" rating in a research note issued on Wednesday, The Fly reports.

Several other analysts also recently issued reports on MGA. Morgan Stanley raised Magna International from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $61.00 to $96.00 in a research note on Wednesday, April 14th. BMO Capital Markets lifted their price target on Magna International from $108.00 to $115.00 and gave the company an "outperform" rating in a research note on Monday, May 31st. Wells Fargo & Company initiated coverage on Magna International in a research note on Wednesday, March 31st. They issued an "equal weight" rating and a $96.00 price target on the stock. Zacks Investment Research downgraded Magna International from a "strong-buy" rating to a "hold" rating and set a $100.00 price target on the stock. in a research note on Friday, April 23rd. Finally, Barclays raised Magna International from an "equal weight" rating to an "overweight" rating in a research note on Thursday, April 15th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock presently has a consensus rating of "Buy" and a consensus target price of $89.47. Read more …

 


GlaxoSmithKline (NYSE:GSK) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “sell” rating to a “hold” rating in a research report issued on Wednesday, The Fly reports.

GSK has been the subject of several other research reports. Morgan Stanley reiterated an “equal weight” rating on shares of GlaxoSmithKline in a research note on Tuesday, April 20th. SVB Leerink reiterated a “market perform” rating on shares of GlaxoSmithKline in a research note on Monday, March 29th. UBS Group restated a “neutral” rating on shares of GlaxoSmithKline in a research note on Tuesday, May 11th. Zacks Investment Research upgraded GlaxoSmithKline from a “strong sell” rating to a “hold” rating and set a $40.00 target price for the company in a research note on Tuesday, April 20th. Finally, Baader Bank restated a “buy” rating on shares of GlaxoSmithKline in a research note on Wednesday, June 2nd. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $40.00. Read more …

 


Nokia (NYSE:NOK) was upgraded by investment analysts at The Goldman Sachs Group from a "neutral" rating to a "buy" rating in a note issued to investors on Thursday, The Fly reports.

A number of other equities analysts have also recently weighed in on the company. Morgan Stanley raised Nokia from an "equal weight" rating to an "overweight" rating in a report on Friday, May 7th. Barclays reissued an "equal weight" rating on shares of Nokia in a report on Thursday, May 13th. SEB Equity Research raised Nokia from a "hold" rating to a "buy" rating in a report on Friday, April 30th. DZ Bank raised Nokia from a "sell" rating to a "hold" rating in a report on Wednesday, March 24th. Finally, Credit Suisse Group reissued a "neutral" rating on shares of Nokia in a report on Friday, April 30th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the company's stock. Nokia presently has an average rating of "Hold" and an average target price of $6.00. Read more …

 

 


Duke Energy (NYSE:DUK) was upgraded by stock analysts at Argus from a "hold" rating to a "buy" rating in a research note issued to investors on Friday, The Fly reports.

A number of other equities research analysts have also commented on DUK. Mizuho upped their target price on Duke Energy from $96.00 to $105.00 and gave the company a "neutral" rating in a research report on Wednesday, May 12th. Morgan Stanley upped their target price on Duke Energy from $107.00 to $108.00 and gave the company an "equal weight" rating in a research report on Monday. Credit Suisse Group upped their target price on Duke Energy from $96.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, April 14th. Zacks Investment Research upgraded Duke Energy from a "hold" rating to a "buy" rating and set a $106.00 target price on the stock in a research report on Friday, April 16th. Finally, Wells Fargo & Company upped their target price on Duke Energy from $97.00 to $104.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 14th. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has an average rating of "Hold" and an average target price of $102.82. Read more …

 

 

Downgrades:

 


H.B. Fuller (NYSE:FUL) was downgraded by research analysts at Citigroup from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Friday, The Fly reports.

A number of other research analysts have also commented on FUL. Zacks Investment Research lowered H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, May 31st. Deutsche Bank Aktiengesellschaft raised their price target on H.B. Fuller from $56.00 to $65.00 and gave the company a “hold” rating in a report on Monday, March 29th. Finally, Robert W. Baird raised their price target on H.B. Fuller from $65.00 to $72.00 and gave the company an “outperform” rating in a report on Friday, March 26th. They noted that the move was a valuation call. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $63.00. Read more …

 

No comments:

Post a Comment